Novasomes as Nano-Vesicular Carriers to Enhance Topical Delivery of Fluconazole: A New Approach to Treat Fungal Infections

The occurrence of fungal infections has increased over the past two decades. It is observed that superficial fungal infections are treated by conventional dosage forms, which are incapable of treating deep infections due to the barrier activity possessed by the stratum corneum of the skin. This is why the need for a topical preparation with advanced penetration techniques has arisen. This research aimed to encapsulate fluconazole (FLZ) in a novasome in order to improve the topical delivery. The novasomes were prepared using the ethanol injection technique and characterized for percent entrapment efficiency (EE), particle size (PS), zeta potential (ZP), drug release, Fourier-transform infrared spectroscopy (FTIR), differential scanning calorimetry (DSC), thermogravimetric analysis (TGA), scanning electron microscopy (SEM) and antifungal activity. The FN7 formulation with 94.45% EE, 110 nm PS and −24 ZP proved to be the best formulation. The FN7 formulation showed a 96% release of FLZ in 8 h. FTIR showed the compatibility of FLZ with excipients and DSC studies confirmed the thermal stability of FLZ in the developed formulation. The FN7 formulation showed superior inhibition of the growth of Candida albicans compared to the FLZ suspension using a resazurin reduction assay, suggesting high efficacy in inhibiting fungal growth.

[1]  Marzina Ajrin,et al.  Proniosome: A Promising Approach for Vesicular Drug Delivery. , 2021, Turkish journal of pharmaceutical sciences.

[2]  Khalid J. Alzahrani,et al.  Formulation Development, Characterization and Antifungal Evaluation of Chitosan NPs for Topical Delivery of Voriconazole In Vitro and Ex Vivo , 2021, Polymers.

[3]  Apichart Atipairin,et al.  Formula Development of Red Palm (Elaeis guineensis) Fruit Extract Loaded with Solid Lipid Nanoparticles Containing Creams and Its Anti-Aging Efficacy in Healthy Volunteers , 2021, Cosmetics.

[4]  S. Nair,et al.  NOVASOME: A PIONEERING ADVANCEMENTIN VESICULAR DRUG DELIVERY , 2021, International Journal of Applied Pharmaceutics.

[5]  Ahmed Abdelbary,et al.  Use of Novasomes as a Vesicular Carrier for Improving the Topical Delivery of Terconazole: In Vitro Characterization, In Vivo Assessment and Exploratory Clinical Experimentation , 2021, International journal of nanomedicine.

[6]  S. Mirzaeei,et al.  A Review on Ocular Novel Drug Delivery Systems of Antifungal Drugs: Functional Evaluation and Comparison of Conventional and Novel Dosage Forms , 2020, Advanced pharmaceutical bulletin.

[7]  Chih-Jung Chang,et al.  Synergistic Antifungal Activity of Chitosan with Fluconazole against Candida albicans, Candida tropicalis, and Fluconazole-Resistant Strains , 2020, Molecules.

[8]  Andrey Kuskov,et al.  Modulation of Entrapment Efficiency and In Vitro Release Properties of BSA-Loaded Chitosan Microparticles Cross-Linked with Citric Acid as a Potential Protein–Drug Delivery System , 2020, Materials.

[9]  G. M. Soliman,et al.  Spironolactone-Loaded LeciPlexes as Potential Topical Delivery Systems for Female Acne: In Vitro Appraisal and Ex Vivo Skin Permeability Studies , 2019, Pharmaceutics.

[10]  P. Szymczyk,et al.  Stabilisation and Growth of Metastable Form II of Fluconazole in Amorphous Solid Dispersions , 2019, Pharmaceutics.

[11]  D. Murzin,et al.  Zeta Potential of Beta Zeolites: Influence of Structure, Acidity, pH, Temperature and Concentration , 2018, Molecules.

[12]  E. Bendas,et al.  Fluconazole-loaded solid lipid nanoparticles topical gel for treatment of pityriasis versicolor: formulation and clinical study , 2017, Drug delivery.

[13]  Mirza Salman Baig,et al.  Application of Box-Behnken design for preparation of levofloxacin-loaded stearic acid solid lipid nanoparticles for ocular delivery: Optimization, in vitro release, ocular tolerance, and antibacterial activity. , 2016, International journal of biological macromolecules.

[14]  P. Dunlop,et al.  Resazurin-based 96-well plate microdilution method for the determination of minimum inhibitory concentration of biosurfactants , 2016, Biotechnology Letters.

[15]  M. Balouiri,et al.  Methods for in vitro evaluating antimicrobial activity: A review☆ , 2015, Journal of pharmaceutical analysis.

[16]  Bin Zhang,et al.  Dispersion Process and Effect of Oleic Acid on Properties of Cellulose Sulfate- Oleic Acid Composite Film , 2015, Materials.

[17]  Jun-Ho Kim,et al.  Evaluation of silica nanoparticle toxicity after topical exposure for 90 days , 2014, International journal of nanomedicine.

[18]  L. Kumar,et al.  Eradication of superficial fungal infections by conventional and novel approaches: a comprehensive review , 2014, Artificial cells, nanomedicine, and biotechnology.

[19]  S. Jose,et al.  Transferosomes - A vesicular transdermal delivery system for enhanced drug permeation , 2011, Journal of advanced pharmaceutical technology & research.

[20]  A. Fadda,et al.  Vesicular carriers for dermal drug delivery , 2009, Expert opinion on drug delivery.

[21]  M. Tunney,et al.  Rapid Colorimetric Assay for Antimicrobial Susceptibility Testing of Pseudomonas aeruginosa , 2004, Antimicrobial Agents and Chemotherapy.

[22]  Christopher P. Austin,et al.  Cell Viability Assays -- Assay Guidance Manual , 2004 .